U.S. market Closed. Opens in 11 hours 10 minutes

TOIIW | The Oncology Institute, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-312018-12-31
Revenue324.24M309.88M252.48M252.48M203.00M203.00M187.51M187.51M155.41M113.16M
Cost of Revenue270.54M249.05M200.39M200.39M162.16M162.16M150.64M150.64M125.46M86.88M
Gross Profit53.70M60.82M52.09M52.09M40.85M40.85M36.88M36.88M29.94M26.28M
Operating Expenses113.74M120.82M124.10M124.10M86.71M86.71M45.07M45.07M32.59M21.49M
Selling, General & Admin113.74M115.33M119.69M119.69M83.36M83.36M41.90M41.90M29.64M20.39M
Research & DevelopmentN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses-704.00K319.00K4.41M4.41M3.34M3.34M3.18M3.18M2.94M1.10M
Operating Income-60.04M-86.81M-72.01M-72.01M-45.86M-45.86M-8.20M-8.20M-2.63M4.79M
Other Expenses / Income-23.07M-8.13M73.91M73.91M34.26M34.26M-6.62M-6.62M-3.38K71.17K
Before Tax Income-83.10M-75.41M1.90M1.90M-11.60M-11.60M-14.81M-14.81M-2.64M4.86M
Income Tax Expenses-36.00K-89.00K247.00K247.00K-671.00K-671.00K-492.82K-492.82K1.38M912.75K
Net Income-67.88M-75.32M1.66M1.66M-10.93M-10.93M-14.32M-14.32M-4.02M3.95M
Interest Expenses6.78M10.47M4.08M4.08M320.00K320.00K347.06K347.06K3.38K1.59K
Basic Shares Outstanding73.75MN/A72.79M72.79M66.23M66.23M64.45M59.12M64.45M28.75M
Diluted Shares Outstanding73.75MN/A80.61M80.61M66.23M66.23M64.45M59.12M64.45M28.75M
EBITDA-54.16M-51.01M-67.10M-67.10M-41.47M-41.47M-11.29M-11.29M307.11K5.96M
EBITDA Margin-16.70%-16.46%-26.57%-26.57%-20.43%-20.43%-6.02%-6.02%0.20%5.27%
EBIT-61.14M-64.94M5.99M5.99M-11.28M-11.28M-14.47M-14.47M-2.63M4.86M
EBIT Margin-18.86%-20.96%2.37%2.37%-5.56%-5.56%-7.72%-7.72%-1.70%4.30%
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙